SQZ Biotechnologies shareholders are set to meet in two weeks to vote on the board’s recommendation that the company sell its assets to an old partner and dissolve. Armon Sharei, its co-founder and former CEO, intends to vote yes.
Sharei — who left SQZ in late 2022 along with 60% of the staff as part of a strategic shift — declared his intentions in a LinkedIn post addressed to SQZ shareholders.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.